Comparison of the influence of 1% and 0.01% atropine on the corneal topography in myopic children. [PDF]
Zhao LQ +8 more
europepmc +1 more source
Therapeutic Potential of 1-(2-Chlorophenyl)-6,7-dimethoxy-3-methyl-3,4-dihydroisoquinoline. [PDF]
Slavchev V +5 more
europepmc +1 more source
Habu snakes (Protobothrops flavoviridis) show variation in thoracic aortic vasoreactivity between adjacent Japanese islands. [PDF]
Ootawa T +8 more
europepmc +1 more source
Pharmacological interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units: a network meta-analysis. [PDF]
Toews I +11 more
europepmc +1 more source
Related searches:
Pyrimidobenzodiazepines. Synthesis of pirenzepine analog.
Die Pharmazie, 1990The synthesis of Pyrimido[4,5-b][1,5]benzodiazepine derivatives from 4-(o-aminophenylene)amino-5-ethoxy-carbonyl-1,2-dihydro-6-methyl-2 - oxopyrimidine has been described. Pyrimidobenzodiazepine 5 alkylated with N-methyl-N'-chloroacetyl-piperazine gives a product related to pirenzepine. Compound 5 shows weak antianxiety and antidepressive action.
Długosz, Anna, Machoń, Zdzisław
openaire +2 more sources
Central oxotremorine antagonist properties of pirenzepine
Life Sciences, 1988Pirenzepine, the prototype M1 muscarinic receptor antagonist, is an important compound for investigating the functional significance of M1 receptors at the integrated level of behavior but may have limitations imposed by its physical chemistry. Like the nonselective antagonist methylatropine, pirenzepine is highly hydrophilic and crosses the blood ...
J M, Witkin +3 more
openaire +2 more sources
Pirenzepine and Gastrointestinal Motility: Differential Effect of Pirenzepine in the Gut
1985The capacity of pirenzepine to reduce gastric acid secretion in the basal state and after various forms of stimulation is well established by now (Jaup 1981). It is still under discussion whether the ulcer-healing and symptom-relieving effect of pirenzepine is solely due to the moderate acid reduction observed or whether other pharmacological ...
R. W. Stockbrügger +3 more
openaire +1 more source
PLASMA AND BILIARY DISPOSITION OF PIRENZEPINE IN MAN
Clinical and Experimental Pharmacology and Physiology, 1986SUMMARY1. The binding of pirenzepine, a selective muscarinic receptor antagonist to plasma and bile, was studied in vitro and in vivo. Plasma and hepatic bile were incubated with 14C‐pirenzepine and the bound fraction of 14C‐pirenzepine determined by equilibrium dialysis. The bound fractions were 12.6% (s.e.m.
Lee, SP, Paxton, JW, Choong, YS
openaire +4 more sources
Absolute bioavailability of pirenzepine in intensive care patients
European Journal of Clinical Pharmacology, 1990The absolute bioavailability (f) of pirenzepine was determined in 27 intensive care patients receiving the drug for prophylaxis and therapy of upper gastrointestinal tract bleeding. A multiple oral and intravenous dosage regimen and the times of blood sampling were adapted to individual conditions and treatment.
P, Tanswell +5 more
openaire +2 more sources
Pirenzepine Inhibits Pancreatic Exocrine Secretion in the Rat
Pancreas, 1986Pirenzepine is a newly developed anticholinergic drug that reduces gastric acid secretion and is therefore used in Europe and Japan to treat patients with peptic ulcer. The inhibitory effect of pirenzepine on pancreatic exocrine function and its reversibility were studied in the isolated pancreatic acini and the isolated perfused pancreas of rats.
M, Otsuki +5 more
openaire +2 more sources

